[1]
|
Siegel, R.L., Miller, K.D., Fuchs, H.E., et al. (2021) Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 71, 7-33. https://doi.org/10.3322/caac.21654
|
[2]
|
Hundahl, S.A., Fleming, I.D., Fremgen, A.M., et al. (1998) A National Cancer Data Base Report on 53,856 Cases of Thyroid Carcinoma Treated in the U.S., 1985-1995. Cancer, 83, 2638-2648.
https://doi.org/10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1
|
[3]
|
Mazzaferri, E.L. and Kloos, R.T. (2001) Clinical Review 128: Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer. The Journal of Clinical Endocrinology and Metabolism, 86, 1447-1463.
https://doi.org/10.1210/jcem.86.4.7407
|
[4]
|
Huang, I.C., Chou, F.F., Liu, R.T., et al. (2012) Long-Term Outcomes of Distant Metastasis from Differentiated Thyroid Carcinoma. Clinical Endocrinology, 76, 439-447. https://doi.org/10.1111/j.1365-2265.2011.04231.x
|
[5]
|
Balachanddran, V.P., Gonen, M., Smith, J.J., et al. (2015) Nomograms in Oncology: More than Meets the Eye. The Lancet Oncology, 16, e173-e180. https://doi.org/10.1016/S1470-2045(14)71116-7
|
[6]
|
Song, H.J., Qiu, Z.L., Shen, C.T., et al. (2015) Pulmonary Metastases in Differentiated Thyroid Cancer: Efficacy of Radioiodine Therapy and Prognostic Factors. European Journal of Endocrinology, 173, 399-408.
https://doi.org/10.1530/EJE-15-0296
|
[7]
|
Lin, Z., Yan, S., Zhang, J., et al. (2018) A Nomogram for Distinction and Potential Prediction of Liver Metastasis in Breast Cancer Patients. Journal of Cancer, 9, 2098-2106. https://doi.org/10.7150/jca.24445
|
[8]
|
Heagerty, P.J., Lumley, T. and Pepe, M.S. (2000) Time-Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker. Biometrics, 56, 337-344. https://doi.org/10.1111/j.0006-341X.2000.00337.x
|
[9]
|
Uka, K., Chayama, K., Aikata, H., et al. (2007) Clinical Features and Prognosis of Patients with Extrahepatic Metastases from Hepatocellular Carcinoma. World Journal of Gastroenterology, 13, 414-420.
https://doi.org/10.3748/wjg.v13.i3.414
|
[10]
|
Vickers, A.J. and Elkin, E.B. (2006) Decision Curve Analysis: A Novel Method for Evaluating Prediction Models. Medical Decision Making, 26, 565-574. https://doi.org/10.1177/0272989X06295361
|
[11]
|
Randle, R.W., Bushman, N.M., Orne, J., et al. (2017) Papillary Thyroid Cancer: The Good and Bad of the “Good Cancer”. Thyroid, 27, 902-907.
|
[12]
|
Lin, J.D., Chao, T.C., Chou, S.C., et al. (2004) Papillary Thyroid Carcinomas with Lung Metastases. Thyroid, 14, 1091-1096. https://doi.org/10.1089/thy.2004.14.1091
|
[13]
|
Nixon, I.J., Whitcher, M.M., Palmer, F.L., et al. (2012) The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid Gland. Thyroid, 22, 884-889.
https://doi.org/10.1089/thy.2011.0535
|
[14]
|
Cho, S.W., Choi, H.S., Yeom, G.J., et al. (2014) Long-Term Prognosis of Differentiated Thyroid Cancer with Lung Metastasis in Korea and Its Prognostic Factors. Thyroid, 24, 277-286. https://doi.org/10.1089/thy.2012.0654
|
[15]
|
Chopra, S., Garg, A., Ballal, S., et al. (2015) Lung Metastases from Differentiated Thyroid Carcinoma: Prognostic Factors Related to Remission and Disease-Free Survival. Clinical Endocrinology, 82, 445-452.
https://doi.org/10.1111/cen.12558
|
[16]
|
Tang, J., Kong, D., Cui, Q.X., et al. (2018) Racial Disparities of Differentiated Thyroid Carcinoma: Clinical Behavior, Treatments, and Long-Term Outcomes. World Journal of Surgical Oncology, 16, 45.
https://doi.org/10.1186/s12957-018-1340-7
|
[17]
|
Brierley, J., Tsang, R., Panzarella, T., et al. (2010) Prognostic Factors and the Effect of Treatment with Radioactive Iodine and External Beam Radiation on Patients with Differentiated Thyroid Cancer Seen at a Single Institution over 40 Years. Clinical Endocrinology, 63, 418-427. https://doi.org/10.1111/j.1365-2265.2005.02358.x
|
[18]
|
Hu, P., Bai, J., Liu, M., et al. (2020) Trends of Incidence and Prognosis of Gastric Neuroendocrine Neoplasms: A Study Based on SEER and Our Multicenter Research. Gastric Cancer, 23, 591-599.
https://doi.org/10.1007/s10120-020-01046-8
|
[19]
|
Huang, R., Sun, Z., Zheng, H., et al. (2019) Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database. Orthopaedic Surgery, 11, 801-810.
https://doi.org/10.1111/os.12521
|
[20]
|
Ito, Y., Fukushima, M., Kihara, M., et al. (2012) Investigation of the Prognosis of Patients with Papillary Thyroid Carcinoma by Tumor Size. Endocrine Journal, 59, 457-464. https://doi.org/10.1507/endocrj.EJ12-0013
|
[21]
|
Salvatori, M., Perotti, G., Rufini, V., et al. (2004) Solitary Liver Metastasis from Hürthle Cell Thyroid Cancer: A Case Report and Review of the Literature. Journal of Endocrinological Investigation, 27, 52-56.
https://doi.org/10.1007/BF03350911
|
[22]
|
Song, H.J., Xue, Y.L., Qiu, Z.L., et al. (2012) Uncommon Metastases from Differentiated Thyroid Carcinoma. Hellenic Journal of Nuclear Medicine, 15, 233-240.
|
[23]
|
Nakanishi, K., Kikumori, T., Miyajima, N., et al. (2018) Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma. Clinical Nuclear Medicine, 43, 482-485.
https://doi.org/10.1097/RLU.0000000000002078
|
[24]
|
Li, C., Wu, Q. and Sun, S.R. (2020) Radioactive Iodine Therapy in Patients with Thyroid Carcinoma with Distant Metastases: A SEER-Based Study. Cancer Control, 27, 1-9. https://doi.org/10.1177/1073274820914661
|
[25]
|
Haugen, B.R., Aleander, L.E.K., Bible, K.C., et al. (2015) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26, 1-133.
https://doi.org/10.1089/thy.2015.0020
|